Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less
- 1 April 1996
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 128 (4), 470-478
- https://doi.org/10.1016/s0022-3476(96)70356-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Changing trends in the epidemiology and pathogenesis of neonatal chronic lung diseaseThe Journal of Pediatrics, 1995
- Diagnostic value of plasma levels of tumor necrosis factor α (TNFα) and interleukin‐6 (IL‐6) in newborns with sepsisActa Paediatrica, 1994
- Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms.Journal of Clinical Investigation, 1992
- Serum tumour necrosis factor in newborns at risk for infectionsEuropean Journal of Pediatrics, 1990
- EFFECT OF BACTERIAL PRODUCTS ON PROSTAGLANDIN E PRODUCTION BY AMNION CELLSThe Lancet, 1985
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Effect of Fluid Administration on the Development of Symptomatic Patent Ductus Arteriosus and Congestive Heart Failure in Premature InfantsNew England Journal of Medicine, 1980
- Lung Compliance in Newborns with Patent Ductus Arteriosus before and after Surgical LigationNeonatology, 1980
- Age-dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandinsThe Journal of Pediatrics, 1980
- PLASMA-PROSTAGLANDINS IN PRE-TERM NEONATES BEFORE AND AFTER TREATMENT FOR PATENT DUCTUS ARTERIOSUSThe Lancet, 1978